Cargando…
Severe exacerbation of immune thrombocytopenia and COVID-19: the favorable response to corticosteroid-based therapy—a case report
Autores principales: | Hu, Zhiliang, Chen, Wei, Liang, Wenyan, Xu, Chuanjun, Sun, Wenkui, Yi, Yongxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270513/ https://www.ncbi.nlm.nih.gov/pubmed/32500224 http://dx.doi.org/10.1007/s00277-020-04070-x |
Ejemplares similares
-
Humoral response to mRNA‐based COVID‐19 vaccine in patients with de novo and pre‐existing immune thrombocytopenia with exacerbation of thrombocytopenia after vaccination
por: Mori, Akio, et al.
Publicado: (2022) -
Clinical Use of Short-Course and Low-Dose Corticosteroids in Patients With Non-severe COVID-19 During Pneumonia Progression
por: Hu, Zhiliang, et al.
Publicado: (2020) -
Vincristine therapy for severe and refractory immune thrombocytopenia following COVID-19 vaccination
por: Saito, Kei, et al.
Publicado: (2021) -
Use of Plasma Therapy for Severe Fever with Thrombocytopenia Syndrome Encephalopathy
por: Park, Se Yoon, et al.
Publicado: (2016) -
Acute exacerbation of pulmonary toxoplasmosis during corticosteroid therapy for immune thrombocytopenia: A case report and literature review
por: Omori, Koji, et al.
Publicado: (2021)